CWA Asset Management »

Aclaris Therapeutics shares owned by CWA Asset Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by CWA Asset Management from 13F filings

Historical chart of CWA Asset Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by CWA Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by CWA Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $101k 15k 6.85

More positions owned by CWA Asset Management

Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Apple (AAPL)
Franco-Nevada Corporation (FNV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Johnson & Johnson (JNJ)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Ishares Tr National Mun Etf (MUB)
Costco Wholesale Corporation (COST)
Cameco Corporation (CCJ)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for CWA Asset Management

Top funds holding Aclaris Therapeutics

BML Capital Management
Citadel Advisors
Vanguard Group
Millennium Management
D. E. Shaw & Co
Tang Capital Management
GSA Capital Partners
Two Sigma Investments
Two Sigma Advisers
Monaco Asset Management SAM
Deutsche Bank Aktiengesellschaft
Jacobs Levy Equity Management
Samsara BioCapital
Goldman Sachs Group
Citigroup

View all funds holding Aclaris Therapeutics